Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003111054 | SCV003792177 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2022-05-26 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 8 of the SGCD gene. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to disrupt the C-terminus of the protein. This variant has not been reported in the literature in individuals affected with SGCD-related conditions. This variant disrupts a region of the SGCD protein in which other variant(s) (p.Thr220Profs*6) have been determined to be pathogenic (PMID: 8841194). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |